OccuLogix is now TearLab
This article was originally published in The Gray Sheet
Executive SummaryOccuLogix changes its name to TearLab, effective May 21, "to better align our corporate brand with our vision to become the leader in tear testing and biomarker analysis at the point-of-care," the firm says
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.